Literature DB >> 1401066

Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.

X C Jiang1, L B Agellon, A Walsh, J L Breslow, A Tall.   

Abstract

To investigate the regulation of expression of the human cholesteryl ester transfer protein (CETP) gene, transgenic mice were prepared using a CETP minigene linked to the natural flanking sequences of the human CETP gene. By using a transgene containing 3.2 kb of upstream and 2.0 kb of downstream flanking sequence, five different lines of transgenic mice were generated. The abundance of CETP mRNA in various tissues was determined on standard laboratory diet or high fat, high cholesterol diets. In three lines of transgenic mice the tissues expressing the human CETP mRNA were similar to those in humans (liver, spleen, small intestine, kidney, and adipose tissue); in two lines expression was more restricted. There was a marked (4-10-fold) induction of liver CETP mRNA in response to a high fat, high cholesterol diet. The increase in hepatic CETP mRNA was accompanied by a fivefold increase in transcription rate of the CETP transgene, and a 2.5-fold increase in plasma CETP mass and activity. In contrast, CETP transgenic mice, in which the CETP minigene was linked to a metallothionein promoter rather than to its own flanking sequences, showed no change in liver CETP mRNA in response to a high cholesterol diet. Thus (a) the CETP minigene or natural flanking sequences contain elements directing authentic tissue-specific expression; (b) a high cholesterol diet induces CETP transgene transcription, causing increased hepatic CETP mRNA and plasma CETP; (c) this cholesterol response requires DNA sequences contained in the natural flanking regions of the human CETP gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401066      PMCID: PMC443172          DOI: 10.1172/JCI115993

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Plasma lipid transfer activities.

Authors:  D W Quig; D B Zilversmit
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

Review 2.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

3.  Structure of the rat gene encoding cholesterol 7 alpha-hydroxylase.

Authors:  D F Jelinek; D W Russell
Journal:  Biochemistry       Date:  1990-08-28       Impact factor: 3.162

Review 4.  Activators and targets.

Authors:  M Ptashne; A A Gann
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

5.  Synthetic low and high fat diets for the study of atherosclerosis in the mouse.

Authors:  P M Nishina; J Verstuyft; B Paigen
Journal:  J Lipid Res       Date:  1990-05       Impact factor: 5.922

6.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice.

Authors:  L B Agellon; A Walsh; T Hayek; P Moulin; X C Jiang; S A Shelanski; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

7.  Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.

Authors:  E M Quinet; L B Agellon; P A Kroon; Y L Marcel; Y C Lee; M E Whitlock; A R Tall
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis.

Authors:  D F Jelinek; S Andersson; C A Slaughter; D W Russell
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

9.  Organization of the human cholesteryl ester transfer protein gene.

Authors:  L B Agellon; E M Quinet; T G Gillette; D T Drayna; M L Brown; A R Tall
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

10.  Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

Authors:  Y L Marcel; R McPherson; M Hogue; H Czarnecka; Z Zawadzki; P K Weech; M E Whitlock; A R Tall; R W Milne
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more
  61 in total

1.  Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.

Authors:  Silvia Bijland; Elsbet J Pieterman; Annemarie C E Maas; José W A van der Hoorn; Marjan J van Erk; Jan B van Klinken; Louis M Havekes; Ko Willems van Dijk; Hans M G Princen; Patrick C N Rensen
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

Authors:  Silvia Bijland; Sjoerd A A van den Berg; Peter J Voshol; Anita M van den Hoek; Hans M G Princen; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

3.  Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins.

Authors:  Amanda L Brown; J Mark Brown
Journal:  J Lipid Res       Date:  2017-04-21       Impact factor: 5.922

4.  Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice.

Authors:  Jianing Li; Sonja S Pijut; Yuhuan Wang; Ailing Ji; Rupinder Kaur; Ryan E Temel; Deneys R van der Westhuyzen; Gregory A Graf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

5.  Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production.

Authors:  Menno Hoekstra; Dan Ye; Reeni B Hildebrand; Ying Zhao; Bart Lammers; Miranda Stitzinger; Johan Kuiper; Theo J C Van Berkel; Miranda Van Eck
Journal:  J Lipid Res       Date:  2009-01-28       Impact factor: 5.922

6.  Bone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the LDLr.

Authors:  Neil J Hime; Audrey S Black; David J Bonnet; Linda K Curtiss
Journal:  J Lipid Res       Date:  2014-05-12       Impact factor: 5.922

7.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.

Authors:  Thomas Gautier; David Masson; Miek C Jong; Jean-Paul Pais de Barros; Linda Duverneuil; Naig Le Guern; Valérie Deckert; Laure Dumont; Amandine Bataille; Zoulika Zak; Xian-Cheng Jiang; Louis M Havekes; Laurent Lagrost
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Authors:  B J van Vlijmen; A M van den Maagdenberg; M J Gijbels; H van der Boom; H HogenEsch; R R Frants; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.

Authors:  Eliete J B Bighetti; Patrícia R Patrício; Andrea C Casquero; Jairo A Berti; Helena C F Oliveira
Journal:  Lipids Health Dis       Date:  2009-11-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.